A recent study by Hong et al. showed that the treatment of rats with Puerarin (an isoflavone used for treating Alzheimer’s disease) could considerably improve behavioral performance and the heightened neurogenesis and Tau protein phosphorylation possibly via the FGF2/GSK-3 signaling pathway [252]. This evidence concerns the gene FGF2 and early-onset autosomal dominant Alzheimer disease.